The Clinimetric Spectrum of Poor Response After Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

INTRODUCTION/AIMS: Clinicians regularly modify treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) because of insufficient response, yet it is unclear how changes over time in the recommended outcome measures inform these decisions. We therefore explored which changes were observed in patients deemed to have an insufficient treatment response. METHODS: We selected patients with CIDP who were previously included in various prospective studies, in whom first-line treatment was changed within 6 months due to deterioration or insufficient improvement. Changes in two disability and two impairment measures were analyzed according to commonly used minimal clinically important difference (MCID) thresholds. RESULTS: We included 16 patients. Median time to treatment change was 12 weeks (IQR 6 to 19). In seven patients (44%), treatment change coincided with deterioration on all available outcome measures, and this occurred within 12 weeks of treatment in 6 patients. Earlier change was associated with more severe baseline disability and impairment, and greater magnitude of deterioration. In seven patients (44%), treatment was changed despite (limited) improvement on one or two outcome measures; all of these observations occurred after 12 weeks. DISCUSSION: Earlier treatment change seemed to be associated with clear deterioration on most outcome measures, while later treatment changes were mainly associated with insufficient improvement, reflected by a combination of improvement and worsening in different clinical outcome measures. Our findings suggest that poor response to treatment requires a nuanced consideration of multiple outcome measures, taking the magnitude and consistency of change into account in relation to treatment duration.

Authors

Institutions

Publication Details

Journal
Muscle & Nerve
Published
2026-11-17
DOI
https://doi.org/10.1002/mus.70464
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Clinimetric Spectrum of Poor Response After Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

Laura Zambreanu, Milou R. Michael, Ivana Z. Basta, Pieter A. van Doorn et al.
3 links
Muscle & Nerve
Peripheral Neuropathies and Disorders
article

The Clinimetric Spectrum of Poor Response After Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

Laura Zambreanu, Milou R. Michael, Ivana Z. Basta, Pieter A. van Doorn, Luuk Wieske, Stojan Perić, Filip Eftimov, Robert D. M. Hadden, Michael Peter Lunn, Ivo N. van Schaik, Stevie C. E. Rozing
article en

Abstract

INTRODUCTION/AIMS: Clinicians regularly modify treatment in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) because of insufficient response, yet it is unclear how changes over time in the recommended outcome measures inform these decisions. We therefore explored which changes were observed in patients deemed to have an insufficient treatment response. METHODS: We selected patients with CIDP who were previously included in various prospective studies, in whom first-line treatment was changed within 6 months due to deterioration or insufficient improvement. Changes in two disability and two impairment measures were analyzed according to commonly used minimal clinically important difference (MCID) thresholds. RESULTS: We included 16 patients. Median time to treatment change was 12 weeks (IQR 6 to 19). In seven patients (44%), treatment change coincided with deterioration on all available outcome measures, and this occurred within 12 weeks of treatment in 6 patients. Earlier change was associated with more severe baseline disability and impairment, and greater magnitude of deterioration. In seven patients (44%), treatment was changed despite (limited) improvement on one or two outcome measures; all of these observations occurred after 12 weeks. DISCUSSION: Earlier treatment change seemed to be associated with clear deterioration on most outcome measures, while later treatment changes were mainly associated with insufficient improvement, reflected by a combination of improvement and worsening in different clinical outcome measures. Our findings suggest that poor response to treatment requires a nuanced consideration of multiple outcome measures, taking the magnitude and consistency of change into account in relation to treatment duration.

Muscle & Nerve
Erasmus MC (NL), Amsterdam UMC Location University of Amsterdam (NL), Sanquin (NL), University of Belgrade (RS), Amsterdam Neuroscience (NL), Univerzitetski Klinički Centar Srbije (RS), National Hospital for Neurology and Neurosurgery (GB), Amsterdam University Medical Centers (NL), King's College Hospital (GB), University College London (GB), University of Amsterdam (NL)
Good health and well-being
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon